OR WAIT null SECS
September 23, 2019
FDA has approved Novo Nordisk’s Rybelsus (semaglutide), a glucagon-like peptide receptor protein treatment in oral tablet form for type 2 diabetes.
The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended the approval of AstraZeneca’s Qtrilmet (metformin hydrochloride, saxagliptin, and dapagliflozin) modified-release tablets for treating type-2 diabetes.
September 19, 2019
The company will supply its heparin sodium injection in prefilled syringe form.
September 13, 2019
TrakCel and McKesson have formed a collaboration that is aimed at accelerating commercialization of cell and gene therapies by leveraging services to enable a more efficient development pathway.
September 02, 2019
Research compared the properties of corticosteroids processed by wet and dry milling for use in inhalation formulations.
August 15, 2019
Nemera has acquired a healthcare focused design and innovation consulting firm in Chicago, IL, Insight Product Development, strengthening its presence in North America.
August 02, 2019
Glass vials have come a long way from mere commodities and are now considered an integral part of final drug product.
Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture.
July 24, 2019
Cure Pharmaceutical secured a patent that lets the company load higher drug amounts to its proprietary drug delivery system, CUREfilm.
July 02, 2019
Nanotechnology is enabling enhanced bioavailability, improved stability, and targeted delivery of challenging APIs.